PRX Insider Trading Activity and SEC Form 4 Filings
PRX insider trading summary
No open-market insider purchases or sales of Par Pharmaceutical Companies, Inc. (PRX) have been reported on SEC Form 4 in the past 12 months.
Latest PRX insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Mar 19, 2012 | Peter S Knight | Director | Sell | $30K (800 @ $37.01) |
| Mar 19, 2012 | Peter S Knight | Director | Sell | $22K (600 @ $37.02) |
| Mar 19, 2012 | Peter S Knight | Director | Sell | $19K (500 @ $37.03) |
| Mar 19, 2012 | Peter S Knight | Director | Sell | $4K (100 @ $37.03) |
| Mar 19, 2012 | Ronald M Nordmann | Director | Sell | $109K (2,940 @ $37.01) |
| Mar 19, 2012 | Ronald M Nordmann | Director | Sell | $19K (507 @ $37.02) |
| Mar 19, 2012 | Ronald M Nordmann | Director | Sell | $8K (207 @ $37.03) |
| Mar 19, 2012 | Ronald M Nordmann | Director | Sell | $67K (1,803 @ $37.04) |
| Mar 19, 2012 | Peter S Knight | Director | Sell | $130K (3,500 @ $37.01) |
| Mar 19, 2012 | Peter S Knight | Director | Sell | $26K (700 @ $37.05) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.